DrugPatentWatch Database Preview

Sanofi Company Profile

« Back to Dashboard

What is the competitive landscape for SANOFI, and what generic alternatives to SANOFI drugs are available?

SANOFI has one hundred and fifty approved drugs.

There are seventy-three US patents protecting SANOFI drugs.

Summary for Sanofi

US Patents:	73
Tradenames:	125
Ingredients:	100
NDAs:	150
Patent Litigation for Sanofi:	See patent lawsuits for Sanofi
PTAB Cases with Sanofi as petitioner:	See PTAB cases with Sanofi as petitioner

Drugs and US Patents for Sanofi

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sanofi Aventis Us	KERLONE	betaxolol hydrochloride	TABLET;ORAL	019507-002	Oct 27, 1989		DISCN	No	No
Sanofi Aventis Us	AUBAGIO	teriflunomide	TABLET;ORAL	202992-001	Sep 12, 2012	AB	RX	Yes	No	6,794,410
Sanofi-aventis Us	ADLYXIN	lixisenatide	SOLUTION;SUBCUTANEOUS	208471-002	Jul 27, 2016		RX	Yes	Yes	9,440,029		Y
Sanofi Aventis Us	NICODERM CQ	nicotine	FILM, EXTENDED RELEASE;TRANSDERMAL	020165-004	Aug 2, 1996		OTC	Yes	Yes	8,999,379
Sanofi-aventis Us	ADMELOG SOLOSTAR	insulin lispro	SOLUTION;IV (INFUSION), SUBCUTANEOUS	209196-002	Dec 11, 2017		RX	Yes	No	8,992,486		Y

Expired US Patents for Sanofi

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Sanofi Aventis Us	AVALIDE	hydrochlorothiazide; irbesartan	TABLET;ORAL	020758-003	Aug 31, 1998	5,270,317*PED
Sanofi Aventis Us	NICODERM CQ	nicotine	FILM, EXTENDED RELEASE;TRANSDERMAL	020165-006	Aug 2, 1996	5,462,745
Sanofi Aventis Us	ALLEGRA ALLERGY	fexofenadine hydrochloride	TABLET;ORAL	020872-010	Jan 24, 2011	7,135,571*PED
Sanofi Aventis Us	JEVTANA KIT	cabazitaxel	SOLUTION;INTRAVENOUS	201023-001	Jun 17, 2010	6,372,780
Sanofi Aventis Us	PLAVIX	clopidogrel bisulfate	TABLET;ORAL	020839-001	Nov 17, 1997	4,847,265*PED

Paragraph IV (Patent) Challenges for SANOFI drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Tablets	75 mg, 150 mg and 300 mg		2004-05-25
	Tablets	800 mg		2008-12-04
	Tablets	300 mg		2009-03-04
	Oral Suspension	30 mg/5 mL		2010-01-25
	Oral Solution	0.5 mg/mL		2009-01-14
	Injection	40 mg/mL, 0.5 mL and 2 mL vials		2009-06-30
	Injection	5 mg/mL, 10 mL and 20 mL vials		2007-02-09
	Injection	200 mg/40 mL		2007-07-16
	Extended-release Tablets	6.25 mg		2006-02-24
	Tablets	7 mg and 14 mg		2016-09-12
	Injection	2 mcg/mL, 2 mL ampules		2007-10-15
	Tablets	300 mg/25 mg		2006-06-06
	Injection	2 mcg/mL, 1 mL in 2 mL vial		2011-12-28
	Tablets	400 mg		2013-07-01
	Powder for Oral Suspension	0.8 g/packet and 2.4 g/packet		2009-12-30
	Tablets	150 mg		2007-10-30
	Transdermal System	7 mg/24 hrs, 14 mg/24 hrs, and 21 mg/24 hrs		2014-05-30
	Tablets	5 mg		2007-12-17
	Injection	100 mg/mL, 3 mL vials		2006-12-07
	For Injection	50 mg/vial and 100 mg/vial		2007-02-09
	Injection	5 mg/mL, 40 mL vial		2011-03-23
	Extended-release Tablets	12.5 mg		2006-01-19
	Capsules	0.5 mcg and 2.5 mcg		2009-03-25
	Tablets	150 mg/12.5 mg and 300 mg/12.5 mg		2004-11-10
	Capsules	1 mcg		2010-02-12

Premature patent expirations for SANOFI

Expiration due to failure to pay maintenance fee

Patent Number	Expiration Date

International Patents for Sanofi Drugs

Country	Document Number	Estimated Expiration
Cyprus	1110643
Russian Federation	2246937
Russian Federation	2577451
Poland	348337
Slovenia	1603610

Supplementary Protection Certificates for Sanofi Drugs

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2004005	Lithuania		PRODUCT NAME: INSULIN DETEMIR
1 5019-2013	Slovakia		FIRST REGISTRATION NO/DATE: EU/1/11/676/001 20110317
172	Luxembourg		PRODUCT NAME: SOLVAT ACETONIQUE DU CABAZITAXEL, OU DESIGNE SOLVAT ACETONIQUE DU DIMETHOXY DOCETAXEL OU SOLVAT ACETONIQUE DU (2R,3S)-3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DE 4-ACETOXY-2A-BENZOYLOXY-5BETA,20-EPOXY-1-HYDROXY-7BETA,10A-DIMETHOXY-9-OXO-TAX-11-ENE-13A-YLE(ACETONATE DU CABAZITAXEL)
60026	Netherlands		PRODUCT NAME: INSULINUM LISPRUM, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/96/007/001 - EU/1/96/007/003 19960430
C0009	Belgium		PRODUCT NAME: IRBESARTAN / HYDROCHLOROTHIAZIDE; REGISTRATION NO/DATE: EU/1/98/086/001 19981015

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Sanochemia Corp Usa
• Sanofi
• Sanofi Aventis Us
• Sanofi Us
• Sanofi Us Services